Association of serum fibroblast growth factor 19 levels with arteriosclerosis parameters assessed by arterial stiffness and atherogenic index of plasma in patients with type 2 diabetes

BACKGROUND: The role of serum fibroblast growth factor 19 (FGF19) in arteriosclerosis is not well known. In the present study, we aimed to explore whether serum FGF19 levels were related to arteriosclerosis parameters, including arterial stiffness and atherogenic index of plasma (AIP), in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wang-shu, Tang, Meng-jie, Xu, Tian-li, Su, Jian-bin, Wang, Xue-qin, Xu, Feng, Zhang, Dong-mei, Zhu, Qing, Cao, Jie, Wang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240909/
https://www.ncbi.nlm.nih.gov/pubmed/32477430
http://dx.doi.org/10.1186/s13098-020-00552-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240909/
https://www.ncbi.nlm.nih.gov/pubmed/32477430
http://dx.doi.org/10.1186/s13098-020-00552-0

Ejemplares similares